Table 4.
Performance of the EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) and existing classification and diagnostic criteria for IIM
PERFORMANCE (%) | The EULAR/ACR classification criteria for IIM*
|
Bohan and Peter† [7, 8] | Tanimoto et al. [10] | Targoff et al.† [11] | Dalakas and Hohlfeld† [14] | ENMC Hoogendijk et al.† [15] | |
---|---|---|---|---|---|---|---|
Without muscle biopsy | With muscle biopsy | ||||||
| |||||||
Mean (95% CI) | |||||||
Sensitivity | 87 (84–90) |
93 (89–95) |
98 (96–99) |
96 (94–97) |
93 (90–95) |
6 (5–8) |
52 (48–55) |
Specificity | 82 (77–87) |
88 (83–93) |
55 (50–61) |
31 (25–37) |
89 (84–92) |
99 (98–100) |
97 (95–98) |
| |||||||
Mean | |||||||
Positive predictive value | 90 | 94 | 85 | 80 | 95 | 92 | 96 |
Negative predictive value | 79 | 85 | 90 | 73 | 85 | 43 | 57 |
Correctly classified | 86 | 91 | 86 | 79 | 91 | 45 | 70 |
| |||||||
CORRECT CLASSIFICATION OF IIM PER SUBGROUP‡ (%) | |||||||
| |||||||
Amyopathic dermatomyositis | 94 | 60 | 25 | 14 | 0 | 0 | 0 |
Dermatomyositis | 96 | 98 | 100 | 96 | 99 | 7 | 83 |
Hypomyopathic dermatomyositis | 83 | 100 | 80 | 40 | 67 | 0 | 20 |
Immune-mediated necrotizing myopathy | 100 | 100 | 100 | 100 | 100 | 0 | 10 |
Inclusion body myositis | 58 | 94 | 97 | 97 | 91 | 1 | 1 |
Juvenile dermatomyositis | 97 | 96 | 100 | 96 | 98 | 5 | 86 |
Polymyositis | 79 | 86 | 95 | 100 | 85 | 11 | 9 |
Cutoff for probability: 55%
Definite and probable polymyositis and dermatomyositis
Classification as idiopathic inflammatory myopathy per subgroup out of total number of cases per subgroup, expressed as mean
IIM, idiopathic inflammatory myopathies; ENMC, European Neuromuscular Centre; CI, confidence interval